Stroke Patients Improve with Stem Cells

Long-term stroke patients involved in a small-scale clinical trial of a neural stem-cell therapy show signs of recovery.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A colony of human embryonic stem cells (middle)WIKIMEDIA, RYDDRAGYNIt was thought that stroke victims couldn’t make any sort of recovery more than 6 months after the stroke. But now, five out of nine long-term stroke patients who took part in a Phase 1 clinical trial of a new therapy in which neural stem cells are injected into the damaged parts of the brain have experienced mild to moderate improvements, reported BBC News.

For example, some participants have recovered the ability to move their fingers and grip objects after several years of complete paralysis, while others are now able to walk around their houses without assistance for the first time in years.

“We are seeing things that are interesting and somewhat surprising,” Hugh Muir, a neuroscientist at the University of Glasgow who is leading the work, told the BBC. “My expectation had been that we would see very little change and if we did see change it would be a relatively short-lived temporary change,” added Muir. “[But] we have seen changes that have been maintained over time.”

The treatment was developed by the company ReNeuron, which first created the stem cells 10 years ago from a sample of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies